Electromedical Technologies, Inc Cash Flow Statement
EMED|4 years of annual SEC 10-K data (FY2020-FY2023)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$1M
FY2023
Free Cash Flow
-$2M
FY2023
Capital Expenditures
$149,705
Cash used for long-term assets
Dividends Paid
N/A
FY2023
Electromedical Technologies, Inc used $1M in operating cash flow and negative free cash flow of $2M in FY2023.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Net Income | -$2.6M | -$3.5M | -$8.5M | -$3.9M |
| Depreciation & Amortization | $4.6K | $21.9K | $21.9K | $21.9K |
| Operating Cash Flow | -$1.4M | -$773.3K | -$1.2M | -$1.3M |
| Capital Expenditures | $149.7K | - | - | - |
| Free Cash Flow | -$1.6M | - | - | - |
| FCF Margin | -116.2% | - | - | - |